Pricing Log in Create free account

Sutro Biopharma, Inc. (STRO) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Sutro Biopharma, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Sutro Biopharma, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($166.6M and $164.8M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Sutro Biopharma, Inc. leads on 6 and Zentalis Pharmaceuticals, Inc. on 6.

Valuation

Metric STRO ZNTL Biotechnology median
P/E n/m n/m 10.26
P/S 3.34 n/m 9.18
P/B n/m 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.03 0.34 0.65
EV/Sales (0.08) n/m 8.98
Earnings yield (187.89%) (114.04%) (34.89%)
Free cash flow yield (95.31%) (104.95%) (24.52%)

Profitability

Metric STRO ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (319.57%) 0.00% 0.00%
Net margin (395.25%) 0.00% 0.00%
Free cash flow margin (318.63%) 0.00% 0.00%
Return on equity 266.76% (66.75%) (50.12%)
Return on assets (79.08%) (49.22%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric STRO ZNTL Biotechnology median
Revenue growth (TTM) (56.25%) — 6.26%
EPS growth (last fiscal year) 24.02% 18.03% 29.88%
Revenue growth, 5-year CAGR 19.12% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric STRO ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.32 4.82 4.89
Net debt to EBITDA 0.92 1.59 1.01

Dividend

Metric STRO ZNTL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric STRO ZNTL Biotechnology median
Market cap 164.82m 166.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack